Update on Testing for Emerging Transfusion-Transmitted Infections: Babesia, Zika & Dengue

Please note: AABB reserves the right to make updates to this program.

Live Program Date: Wednesday, July 24, 2019 - On-Demand Available

Master Program Number: 19EL-457 (see program format numbers below under Registration)

Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Physicians, Resident/Fellow, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
Teaching Level: Intermediate

Director/Moderator: Isabella W. Martin, MD, Assistant Professor of Pathology, Medical Director of Microbiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Speaker: Evan Bloch, MD, MS, Associate Professor, Johns Hopkins University School of Medicine, Associate Director, Transfusion Medicine, Johns Hopkins Medical Institutes, Baltimore, MD

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Describe the clinical relevance and geographic distribution of Babesia, Zika virus and Dengue virus.
  • Describe approaches available for donor screening for Babesia, Zika virus and Dengue virus.
  • Describe the impact on the US blood supply of screening and testing for emerging transfusion-transmitted pathogens.

Program Description

This program will review the clinical relevance and geographic distribution of the recently emerging transfusion-transmitted pathogens Babesia, Zika virus and Dengue virus. The current state of regulatory requirements for screening and testing for these infections will be discussed as well as the impact of these interventions on the US blood supply.

Registration

   Program #
Single Viewer: On-Demand Register19EL-457-4035
Group Viewing: On-Demand Register19EL-457-8035

Continuing Education Credit

AABB designates both the live and on-demand version of this eCast each eligible for 1 continuing education credits/contact hours for Physicians, General Participation, California Nurse, California Lab Personnel and Florida Lab Personnel. The number and type of credits awarded for this program (both live and on-demand) was determined by the program duration. For more information on each credit type please visit our Continuing Education Credits webpage.

Disclosures for the planners of this event can be found here. Disclosures for the program faculty are provided at the beginning of the program.

Speaker Biography

Dr. Bloch’s expertise is in the field of neglected (e.g. Babesia) and emerging infectious diseases (e.g. Zika virus), particularly in the context of blood transfusion safety. He has participated in studies to develop both antibody and molecular tests for detection of Babesia. He is a member of the International Society of Blood Transfusion infectious disease working party. He has consulted on transfusion policy and development of clinical transfusion guidelines and hopes to use blood transfusion as a platform for infectious disease surveillance so as to guide programmatic support, particularly in low-resource settings.